Tumour response interpretation with new tumour response criteria vs the World Health Organisation criteria in patients with bone-only metastatic breast cancer

被引:0
|
作者
T Hamaoka
C M Costelloe
J E Madewell
P Liu
D A Berry
R Islam
R L Theriault
G N Hortobagyi
N T Ueno
机构
[1] The University of Texas M. D. Anderson Cancer Center,Department of Stem Cell Transplantation and Cellular Therapy
[2] Breast Cancer,Department of Diagnostic Radiology
[3] St Luke's International Hospital,Department of Biostatistics and Applied Mathematics
[4] The University of Texas M. D. Anderson Cancer Center,Department of Breast Medical Oncology
[5] The University of Texas M. D. Anderson Cancer Center,undefined
[6] The University of Texas M. D. Anderson Cancer Center,undefined
来源
British Journal of Cancer | 2010年 / 102卷
关键词
bone diseases; breast neoplasms; diagnostic imaging; response assessment;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:651 / 657
页数:6
相关论文
共 50 条
  • [31] Systemic T-cells demonstrate a tumour permissive response in breast cancer patients
    M. R. Kell
    J. Connelly
    D. C. Winter
    D. Beddy
    C. Canning
    R. W. G. Watson
    J. M. Fltzpatrick
    M. Kerin
    Irish Journal of Medical Science, 2002, 171 (Suppl 2)
  • [32] A PROSPECTIVE-STUDY OF ALTERNATIVE RESPONSE CRITERIA FOR BONE METASTASES FROM BREAST-CANCER
    COLEMAN, RE
    MASHITER, G
    WHITAKER, KB
    MOSS, DW
    FOGELMAN, IS
    RUBENS, RD
    BRITISH JOURNAL OF CANCER, 1986, 53 (03) : 431 - 431
  • [33] Circulating tumor cells criteria (CyCAR) versus standard RECIST criteria for treatment response assessment in metastatic colorectal cancer patients
    Mayte Delgado-Ureña
    Francisco G. Ortega
    Diego de Miguel-Pérez
    Alba Rodriguez-Martínez
    Jose L. García-Puche
    Hugh Ilyine
    Jose A. Lorente
    Jose Exposito-Hernandez
    M. Carmen Garrido-Navas
    Miguel Delgado-Ramirez
    M. José Serrano
    Journal of Translational Medicine, 16
  • [34] Circulating tumor cells criteria (CyCAR) versus standard RECIST criteria for treatment response assessment in metastatic colorectal cancer patients
    Delgado-Urena, Mayte
    Ortega, Francisco G.
    de Miguel-Perez, Diego
    Rodriguez-Martinez, Alba
    Garcia-Puche, Jose L.
    Ilyine, Hugh
    Lorente, Jose A.
    Exposito-Hernandez, Jose
    Carmen Garrido-Nayas, M.
    Delgado-Ramirez, Miguel
    Jose Serrano, M.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2018, 16
  • [35] Fampridine response in MS patients with gait impairment in a real-world setting: Need for new response criteria?
    Rodriguez-Leal, Francisco Alejandro
    Haase, Rocco
    Thomas, Katja
    Eisele, Judith Christina
    Proschmann, Undine
    Schultheiss, Thorsten
    Kern, Raimar
    Ziemssen, Tjalf
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (10) : 1337 - 1346
  • [36] MONITORING THERAPY RESPONSE IN METASTATIC BREAST CANCER USING TUMOUR MARKERS CA15-3 AND TPS
    Sundquist, Marie
    Nilsson, Joakim
    Tejler, Goran
    BREAST, 2015, 24 : S46 - S46
  • [37] The tumour microenvironment influences long-term tamoxifen treatment response in breast cancer patients
    Romera, P. Camargo
    Romero, M. Rios
    Danielsson, O.
    Dar, H. Akhtar
    Lindstrom, L. S.
    Tobin, N. P.
    ANNALS OF ONCOLOGY, 2024, 35 : S327 - S327
  • [38] Early tumour shrinkage (ETS) and depth of response (DpR) in the treatment of patients with metastatic colorectal cancer (mCRC)
    Heinemann, Volker
    Stintzing, Sebastian
    Modest, Dominik P.
    Giessen-Jung, Clemens
    Michl, Marlies
    Mansmann, Ulrich R.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 (14) : 1927 - 1936
  • [39] Targeted radiotherapy to the skeleton using 166HO-DOTMP with autologous stem cell transplantation for patients with bone-only metastatic breast cancer
    Champlin, RE
    Booser, D
    Rondon, G
    Williams, PA
    Wendt, R
    Hortobagyi, G
    Ueno, N
    Podoloff, D
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2005, 11 (02) : 84 - 85
  • [40] Evaluating tumour response to primary radiochemotherapy in breast cancer patients: what role for breast magnetic resonance imaging?
    Thibault, F.
    Bollet, M. A.
    Tardivon, A.
    Malhaire, C.
    Zemmour-Elfersi, G.
    BREAST CANCER RESEARCH, 2008, 10 (Suppl 3)